Methods of treating dementia using a gm-csf antagonist
AssigneeKaloBios Pharmaceuticals, Inc.
InventorsChristopher R. Bebbington, Geoffrey T. Yarranton, Varghese Palath
Life of this patent
Estimating the term…
Abstract
The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of a patient that has Alzheimer's disease or vascular dementia, or is at risk for developing Alzheimer's disease. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody and pharmaceutical compositions comprising such antagonists.
Claims19
A method for treating a patient suffering from vascular dementia or cerebral amyloid angiopathy, the method comprising administering a recombinant GM-CSF antagonist to the patient, wherein the recombinant GM-CSF antagonist is provided in a therapeutically effective amount.
Dependencies are inferred from the claim text.